Low-dose aspirin: Clinical Trials

3 trials of Low-dose aspirin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Recruiting 1, Unknown 1

Follow Low-dose aspirin: new trials by email Literature Review of Low-dose aspirin trials Research Report on Low-dose aspirin

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aspirin Dose Comparison in Elderly PCI Patients: 30mg vs. 75mg in Acute Coronary Syndrome
Low-dose aspirin - Myocardial Infarction, Acute Coronary Syndrome
Phase 2UnknownMedical University of Warsaw402023-07-032024-02-12
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Biospecimen Collection, Low-Dose Aspirin, Questionnaire Administration - Breast Carcinoma
Phase 2RecruitingMayo Clinic602023-03-092026-10-01
Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply
P1101, Low-dose aspirin, Phlebotomy - Polycythemia Vera (PV)
Phase 2CompletedPharmaEssentia Japan K.K.292019-12-202025-09-15

Conditions studied

Acute Coronary Syndrome (1)  ·  Breast Neoplasms (1)  ·  Myeloproliferative Disorders (1)  ·  Myocardial Infarction (1)  ·  Polycythemia Vera (1)

Sponsors

Mayo Clinic (1)  ·  Medical University of Warsaw (1)  ·  PharmaEssentia Japan K.K. (1)

Countries

Japan (1)  ·  Poland (1)  ·  United States (1)

Top investigators

Kathryn J. Ruddy, MD (1)  ·  Mariusz Tomaniak, PhD (1)

Results publications

PMID 40313042

NIH funding

R01CA262393 (1)